Industrial pollution, mining, and agricultural runoff are severely contaminating our environment with heavy metals. The World Health Organization attributes 1.5 million deaths annually to heavy metal exposure — and current detection methods are too slow, costly, and inaccessible to tackle the crisis at scale.
While conventional methods require 2–10 days and access to centralized labs, FlagSens delivers near-instant detection of heavy metals exactly where contamination occurs. This breakthrough in speed empowers faster decisions, risk mitigation, and regulatory compliance in real time. Our proprietary protein-based biosensors — with IP filing planned for 2025 — enable this unprecedented performance in both sensitivity and turnaround time.
Traditional lab-based analyses are expensive and logistically complex. FlagSens offers a low-cost alternative that maintains high sensitivity — making frequent, wide-scale testing feasible for organizations and communities alike. We democratize biosensing.
FlagSens works with existing field equipment and connects to a mobile app for data capture and visualization. Our integrated solution eliminates the need for specialized infrastructure, enabling rapid deployment in remote or resource-limited environments. The platform is fully aligned with EIT Food priorities — including sustainability, traceability, and circularity — ensuring relevance across the agri-food and environmental sectors.
The demand for effective heavy metal detection is growing rapidly. Our advanced biosensor technology is designed to meet this need, offering quick, accurate, and sustainable solutions.
Our biosensors deliver fast results, enabling timely decision-making for businesses and governments.
Designed to be affordable, our technology allows widespread access to high-quality detection capabilities.
Aligned with global sustainability efforts, our biosensors minimize environmental impact while maximizing efficiency.
Superior sensitivity, unmatched speed, and field-ready design — all at low cost.
FlagSens combines high analytical sensitivity with 20-minute turnaround time, outperforming both traditional lab-based methods and other portable tests. Unlike standard techniques that require 2–10 days and centralized labs, FlagSens is fully portable, affordable, and optimized for field use — including seamless app integration. No compromises between performance and usability.
High
Low
High
2-10 days
Minutes
~20 minutes
❌ Requires lab
✅
✅ + integrated app
High
Moderate
Low
❌
Limited
Optimized for field use
The demand for real-time, in-field biosensing is growing rapidly:
Addressable market by 2032: $28.3 billion
Backed by 20+ years of R&D and successful biosensing projects, our international team spans Hungary and Serbia with strong academic and industrial roots — including from iPASy Technologies and the University of Pannonia.
Dr. Vasa Radonic is a Principal Research Fellow at the Biosense Institute. He received a Ph.D. in Electronics from the University of Novi Sad in 2010. Dr. Radonic has been a research fellow at several universities, including Heriot-Watt University in Edinburgh, Scotland; Stellenbosch University in South Africa; Saint Petersburg Electrotechnical University “LETI” in Russia; and the Technical University of Vienna. He has authored and co-authored two book chapters, 30 journal papers, and more than 40 conference papers. He has led three international projects and participates in several H2020, FP7, COST, Eureka, and national research projects. Dr. Radonic’s current research interests include the design of microfluidic devices, development of various types of sensors and biosensors (microwave, optical, electrochemical, and microfluidic), RF and microwave passive components (filters, couplers, diplexers, etc.), antennas, RFID systems, artificial and nanomaterials, as well as fabrication, measurements, and characterization.
Dr. Hajnalka Jankovics received her PhD degree from the University of Szeged (SZTE), Hungary in 2003 in the field of solution chemistry and solid synthesis of the complexes of organotin(IV) cations and biologically relevant ligands. As a Marie Curie Postdoctoral Fellow at Technical University of Denmark, she extended her scientific experience with recombinant DNA technology techniques, protein expression and purification and the synthesis of artificial metalloproteins. After returning to SZTE she took part in the establishment of a new molecular biology research laboratory. She has been working in the Bio-Nanosystems Laboratory (Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, Veszprém, Hungary) since 2008. Currently she is the leader of the research group and among others works on selecting or engineering and study of flagellin-based polymerizable binding proteins and the development of immobilizable enzymes and specific binder proteins for diagnostic applications or environmental detection.
Dr. Gábor Járvás is an experienced science-driven entrepreneur and business developer with over a decade of leadership in high-tech R&D environments. He has co-founded multiple biotech ventures, including iPASy Technologies and CAPTEC Medical, where he has held executive roles such as CEO and CTO. In these capacities, he has overseen technology translation from academic research to market-ready products, secured IP protection, managed strategic partnerships, and led both operational and fundraising efforts. His business acumen is backed by a strong technical background in analytical chemistry and molecular diagnostics, complemented by hands-on experience in innovation management, regulatory strategy, and product development. Dr. Járvás has successfully exited a previous biotech venture, and is well-versed in scaling early-stage deeptech projects within regulated environments. His entrepreneurial approach is grounded in cross-sectoral collaboration, IP valorization, and sustainable health innovation.
Dr. Nikolina Jankovic is a Senior Research Associate at the Center for Sensing Technologies in the BioSense Institute. She is the author and co-author of more than 40 journal and conference papers and 5 book chapters. Her main research interests include metamaterials, plasmonics, optics, sensors, and microwave passive devices. She is the coordinator of the H2020 MSCA-RISE project NOCTURNO and the EUREKA project WaQUMoS in Serbia. Dr. Janković is well-versed in EU regulations and procedures, as well as EC-funded projects. Over the past seven years, she has participated in two FP7 projects—MultiWaveS and InnoSense (as Financial and Administrative Manager and WP leader)—and in four H2020 projects (H2020 Teaming ANTARES, NOCTURNO, SHealthy, and NANOFACTS).
Dr. Ivana Kundacina is a Research Associate at the BioSense Institute, University of Novi Sad, Serbia. She completed her bachelor’s and master’s degrees in Physics and earned a Ph.D. in Applied Physics from the Faculty of Sciences at the same university. She defended her Ph.D. thesis titled “Development and Implementation of New Sensor and Biosensor Solutions Integrated into the Lab-on-Chip Concept” in 2024. Throughout her career, Dr. Kundacina has been involved in eight national and international research projects and has worked as a visiting researcher at the Technical University of Vienna, Austria, and the French National Institute for Agriculture, Food, and Environment (INRAe) in Paris, France. Her research interests include microfluidics, CFD simulations, and the development of sensing and biosensing solutions integrated into miniaturized systems.